Research Article

Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts

Table 7

Determination of IZD (mm), MIC, and MBC (mg/mL) of C. monspeliensis extracts.

StrainsE. faeciumS. aureusK. pneumoniaeA. baumanniiP. aeruginosaE. cloacae
ExtractsIZD mmMIC mg/mLMBCMBC/MICIZDMICMBCMBC/MICIZDMICMBCMBC/MICIZDMICMBCMBC/MICIZDMICMBCMBC/MICIZDMICMBCMBC/MIC

CMM170.420.852200.010.4232121.756.874150.103.4332120.216.8733140.8527.532
CMS130.420.421140.050.8516913.7513.751120.420.421100.426.876103.4313.754
F1MM110.421.714100.010.054106.8713.75293.433.431103.4213.75483.436.872
F1MS100.420.421100.011.7113196.8713.75283.436.872103.4313.75486.8713.752
F2MM110.100.424110.010.108103.436.872103.436.87291.716.874103.4313.754
F2MS100.211.718100.020.853296.876.87163.436.87273.436.87293.4327.58
F3MM170.851.712170.010.108130.426.8716150.853.434150.026.8733143.4313.754
F3MS140.420.421130.010.8565103.436.872130.050.8516130.023.43131113.4313.754
F4MM140.856.878130.010.856590.8513.7516101.716.874113.436.872106.8727.52
F4MS110.850.851100.103.433270.856.87871.713.43296.876.87186.8727.52
F5MM130.851.712130.050.8516113.436.872101.716.874120.106.8764106.8713.752
F5MS110.851.712100.211.71886.8713.75273.433.43161.716.87486.8727.54

CCMM: crude CM from maceration; CCMS: crude CM from Soxhlet; F1CMM: hexane fraction of CM from maceration; F1CMS: hexane fraction of CM from Soxhlet; F2CMM: dichloromethane fraction of CM from maceration; F2CMS: dichloromethane fraction of CM from Soxhlet; F3CMM: ethyl acetate fraction of CM from maceration; F3CMS: ethyl acetate fraction of CM from Soxhlet; F4CMM: n-butanol fraction of CM from maceration; F4CMS: n-butanol fraction of CM from Soxhlet; F5CMM: remaining aqueous of CM from maceration; F5CMS: remaining aqueous of CM from Soxhlet.